seekingalpha.com
/1 month ago
Latest updates for Mrk
Fresh curated links around MRK are collected here so marketers can spot useful updates and turn timely ideas into posts faster.
Recent items include:
- Merck & Co., Inc. (MRK) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
- <![CDATA[Pharmaceutical Executive Daily: Merck Acquires SPR2015 in $2.13 Billion Licensing Deal]]>
- Merck KGaA to buy Silence Therapeutics in all-cash deal
Post angles to try
Share the most useful takeaway for your audience.
Turn one article into a quick practical checklist.
Ask your audience how this shift affects their work.
Fresh articles and ideas
Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.
pharmexec.com
/3 weeks ago
<![CDATA[Pharmaceutical Executive Daily: Merck Acquires SPR2015 in $2.13 Billion Licensing Deal]]>
pharmexec.com
/5 days ago
<![CDATA[Merck KGaA, Darmstadt, Germany, Acquires Silence Therapeutics for $1.3 Billion ]]>
seekingalpha.com
/1 month ago
Summit’s ivonescimab cuts death risk by 27% versus Keytruda in lung cancer trial
pharmexec.com
/3 weeks ago
<![CDATA[Merck Licenses Preclinical KRAS G12D Inhibitor from SciBrunch]]>
cafepharma.com
/1 day ago
The Merck/Moderna Results
The Merck/Moderna Results Anonymous (not verified) Fri, 10/23/2026 - 13:17 pharmagather item url The Merck/Moderna Results pharmagather...
pharmexec.com
/2 weeks ago
<![CDATA[Roundup: TRexBio & Retension Pharmaceuticals Announce IPO Pricing ]]>
pharmexec.com
/1 month ago
<
pharmexec.com
/3 weeks ago
<![CDATA[MRD Testing Is Becoming the Most Important Tool in Oncology Drug Development: Q&A with Eric Matthews]]&g...
pharmexec.com
/1 month ago
<![CDATA[ Eli Lilly to Acquire Merida Biosciences for $2.8 Billion ]]>
pharmexec.com
/5 days ago
<![CDATA[FDA Grants Accelerated Approval to Jemperli for MSI-H/dMMR Locally Advanced Rectal Cancer]]>
pharmexec.com
/1 month ago
<![CDATA[Novartis & BoomRay Enter Global License Agreement for Preclinical Radioligand Asset]]>
pharmexec.com
/1 month ago
<
seekingalpha.com
/1 month ago
Olema: Best Breast Cancer Therapy, Or SERD Also-Ran? We'll Find Out In Q1 '27
roi-nj.com
/1 month ago
Pharma giant Merck to slash 54 jobs at Rahway headquarters
The pharmaceutical company Merck & Co. has notified state officials that it will lay off 54 workers at its Rahway headquarters, according to a September filing with the New Jer...
medcitynews.com
/3 weeks ago
Merck Pays $400M for Cancer Drug Prospect From China-Based SciBrunch
Merck now has global rights to a SciBrunch Therapeutics drug candidate designed to block mutated versions of the cancer-driving protein KRAS G12D. This class of targeted cancer the...
pharmexec.com
/1 month ago
<![CDATA[Novartis Investors Share Concerns Over M&A Strategy: Report]]>
pharmexec.com
/3 days ago
<![CDATA[The Therapeutic Areas or Deals That Might Be Negatively Impacted by MFN Deals]]>
Turn fresh research into a full content calendar
Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.
Sources covering Mrk
seekingalpha.com
Recent coverage from public sources
Public source
cafepharma.com
Recent coverage from public sources
Public source
medcitynews.com
Recent coverage from public sources
Public source
seekingalpha.com
Recent coverage from public sources
Public source
seekingalpha.com
Recent coverage from public sources
Public source
investing.com
Recent coverage from public sources
Public source